The cost to insure against swings in South Korean equities has surged to unprecedented levels relative to US markets, signaling deep investor anxiety after a historic rally fueled by AI optimism shows signs of fatigue.
Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.
Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.
As Steris prepares to report its fiscal fourth-quarter results, investors are watching to see if the company can maintain its recent streak of topping revenue estimates against a backdrop of mixed signals from the broader healthcare equipment sector.
The affordable cosmetics giant e.l.f. Beauty is poised to release its fourth-quarter financial results this week, following a period of robust stock performance and mixed signals from the broader consumer staples sector.
As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
Samsung Electronics unveils enhanced privacy controls for Galaxy devices and a special Olympic Edition of its foldable phone, aiming to bolster its brand in security and high-profile partnerships while its shares show significant long-term gains.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Shares of cybersecurity firm Gen Digital have tumbled over 7% in a week, pushing its valuation metrics below industry averages. A deep dive into its cash flows and earnings multiples suggests the market may be undervaluing the consumer digital safety provider.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
As Equitable Holdings prepares to report fourth-quarter results, investors are watching for signs of stability amid a turbulent period for insurance stocks. With revenue growth expected to stall, the focus shifts to profitability and guidance.
As Kulicke & Soffa prepares to release its fourth-quarter results, investors are watching to see if the semiconductor equipment specialist can meet elevated expectations amid a sector-wide rebound.
Vertiv's launch of its 'Next Predict' AI service aims to transform data center maintenance. While it strengthens the company's AI infrastructure narrative, investors are weighing rich valuations against execution risks in a maturing growth cycle.
As Everest Group prepares to report its fourth-quarter results, investors are weighing a history of revenue misses against a stabilizing analyst outlook and a mixed performance across the insurance sector.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
As T. Rowe Price Group prepares to release its fourth-quarter results, investors are weighing steady revenue growth expectations against a history of occasional misses and a mixed landscape for custody banks.
Old Dominion Freight Line prepares to release its quarterly results Wednesday morning, with analysts projecting a revenue dip but watching for signs of resilience in a challenging transport market.
